|
Forum di discussione Torna alla Homepage di questo forum - Inserisci un nuovo messaggio |
|
GNacasSpLJO Autore: Marcelo Could you please repeat that? <a href=" http://theacceleratornetwork.com/unterschied-snovitra-lovevitra.pdf#parlour ">extra super lovevitra erfahrungen</a> Pharmaceutical turnover edged up 1% to $7.89 billion, hit by a 14% decline in sales of the blood pressure lowerer Diovan (valsartan) to $835 million, due to generic competition in Europe. Although off-patent in the USA, Novartis is still benefitting from the fact that the Food and Drug Administration has yet to approve any competitor for Diovan monotherapy. |
|
Rispondi |